A Multicenter, Randomized, Double-Blinded, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Topically Applied Sofpironium Bromide Gel, 15% in Subjects With Axillary Hyperhidrosis
Status: Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 05 Aug 2019
Price : $35 *
At a glance
- Drugs Sofpironium bromide (Primary)
- Indications Hyperhidrosis
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms Cardigan I
- Sponsors Brickell Biotech
- 09 Jul 2019 Planned End Date changed from 1 Feb 2020 to 1 Oct 2020.
- 09 Jul 2019 Planned primary completion date changed from 1 Feb 2020 to 1 Oct 2020.
- 09 Jul 2019 Planned initiation date changed from 1 Jun 2019 to 1 Oct 2019.